Amilcar Sabino Damazo

Dr. Amilcar Sabino Damazo

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in The American Journal of Pathology
Verified
Journal Article
Open access
Amilcar Sabino DamazoAmilcar Sabino Damazo
Amilcar Sabino Damazo
SYSimon Yona
Simon Yona
FDFulvio D'ACquisto
Fulvio D'ACquisto
RFRoderick J. Flower
Roderick J. Flower
SOSonia Maria Oliani
Sonia Maria Oliani
MPMauro Perretti
Mauro Perretti
The inflammatory response is a protective process of the body to counteract xenobiotic penetration and injury, although in disease this response can become deregulated. There are endogenous biochemical pathways that operate in the host to keep inflammation under control. Here we demonstrate that the counterregulator annexin 1 (AnxA1) is critical for controlling experimental endotoxemia. Lipopolysaccharide (LPS) markedly activated the AnxA1 gene in epithelial cells, neutrophils, and peritoneal, mesenteric, and alveolar macrophages--cell types known to function in experimental endotoxemia. Administration of LPS to AnxA1-deficient mice produced a toxic response characterized by organ injury and lethality within 48 hours, a phenotype rescued by exogenous application of low doses of the protein. In the absence of AnxA1, LPS generated a deregulated cellular and cytokine response with a marked degree of leukocyte adhesion in the microcirculation. Analysis of LPS receptor expression in AnxA1-null macrophages indicated an aberrant expression of Toll-like receptor 4. In conclusion, this study has detailed cellular and biochemical alterations associated with AnxA1 gene deletion and highlighted the impact of this protective circuit for the correct functioning of the homeostatic response to sublethal doses of LPS.

1 April 2006 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
Amilcar Sabino DamazoAmilcar Sabino Damazo
Amilcar Sabino Damazo
SYSimon Yona
Simon Yona
RFRoderick J. Flower
Roderick J. Flower
MPMauro Perretti
Mauro Perretti
SOSonia Maria Oliani
Sonia Maria Oliani
The recent appreciation of the role played by endogenous counterregulatory mechanisms in controlling the outcome of the host inflammatory response requires specific analysis of their spatial and temporal profiles. In this study, we have focused on the glucocorticoid-regulated anti-inflammatory mediator annexin 1. Induction of peritonitis in wild-type mice rapidly (4 h) produced the expected signs of inflammation, including marked activation of resident cells (e.g., mast cells), migration of blood-borne leukocytes, mirrored by blood neutrophilia. These changes subsided after 48–96 h. In annexin 1null mice, the peritonitis response was exaggerated (∼40% at 4 h), with increased granulocyte migration and cytokine production. In blood leukocytes, annexin 1 gene expression was activated at 4, but not 24, h postzymosan, whereas protein levels were increased at both time points. Locally, endothelial and mast cell annexin 1 gene expression was not detectable in basal conditions, whereas it was switched on during the inflammatory response. The significance of annexin 1 system plasticity in the anti-inflammatory properties of dexamethasone was assessed. Clear induction of annexin 1 gene in response to dexamethasone treatment was evident in the circulating and migrated leukocytes, and in connective tissue mast cells; this was associated with the steroid failure to inhibit leukocyte trafficking, cytokine synthesis, and mast cell degranulation in the annexin 1null mouse. In conclusion, understanding how inflammation is brought under control will help clarify the complex interplay between pro- and anti-inflammatory pathways operating during the host response to injury and infection.

9 January 2007 in Blood
Verified
Journal Article
Open access
PDF file
LMLeonardo A. Moraes
Leonardo A. Moraes
KSKaren E. Swales
Karen E. Swales
JWJessica A. Wray
Jessica A. Wray
Amilcar Sabino DamazoAmilcar Sabino Damazo
Amilcar Sabino Damazo
JGJonathan M. Gibbins
Jonathan M. Gibbins
DBDavid Bishop-Bailey
David Bishop-Bailey
Retinoid X receptors (RXRs) are important transcriptional nuclear hormone receptors, acting as either homodimers or the binding partner for at least one fourth of all the known human nuclear receptors. Functional nongenomic effects of nuclear receptors are poorly understood; however, recently peroxisome proliferator-activated receptor (PPAR) \#947;, PPAR\#946;, and the glucocorticoid receptor have all been found active in human platelets. Human platelets express RXR\#945; and RXR\#946;. RXR ligands inhibit platelet aggregation and TXA2 release to ADP and the TXA2 receptors, but only weakly to collagen. ADP and TXA2 both signal via the G protein, Gq. RXR rapidly binds Gq but not Gi/z/o/t/gust in a ligand-dependent manner and inhibits Gq-induced Rac activation and intracellular calcium release. We propose that RXR ligands may have beneficial clinical actions through inhibition of platelet activation. Furthermore, our results demonstrate a novel nongenomic mode for nuclear receptor action and a functional cross-talk between G-protein and nuclear receptor signaling families.

1 January 2009 in The American Journal of Pathology
Verified
Journal Article
Closed access
TGThaís Santana Gastardelo
Thaís Santana Gastardelo
Amilcar Sabino DamazoAmilcar Sabino Damazo
Amilcar Sabino Damazo
JDJesmond Dalli
Jesmond Dalli
RFRoderick J. Flower
Roderick J. Flower
MPMauro Perretti
Mauro Perretti
SOSonia Maria Oliani
Sonia Maria Oliani

1 September 2007 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
AOAna Paula Ligeiro de Oliveira
Ana Paula Ligeiro de Oliveira
HDHelori Vanni Domingos
Helori Vanni Domingos
GCGabriela Cavriani
Gabriela Cavriani
Amilcar Sabino DamazoAmilcar Sabino Damazo
Amilcar Sabino Damazo
AFAdriana Lino dos Santos Franco
Adriana Lino dos Santos Franco
WLWothan Tavares de Lima
Wothan Tavares de Lima
We evaluated the role of estradiol and progesterone in allergic lung inflammation. Rats were ovariectomized (Ovx) and, 7 days later, were sensitized with ovalbumin (OA) and challenged after 2 wk with inhaled OA; experiments were performed 1 day thereafter. Ovx-allergic rats showed reduced cell recruitment into the bronchoalveolar lavage (BAL) fluid relative to sham-Ovx allergic rats, as was observed in intact allergic rats treated with ICI-182,780. Estradiol increased the number of cells in the BAL of Ovx-allergic rats, whereas progesterone induced an additional reduction. Cells of BAL and bone marrow (BM) of Ovx-allergic rats released elevated amounts of IL-10 and reduced IL-1β and TNF-α. BM cells of Ovx-allergic rats released increased amounts of IL-10 and lower amounts of IL-4. Estradiol treatment of Ovx-allergic rats decreased the release of IL-10 but increased that of IL-4 by BM cells. Estradiol also caused an increased release of IL-1β and TNF-α by BAL cells. Progesterone significantly increased the release of IL-10, IL-1β, and TNF-α by BAL cells and augmented that of IL-4 by BM cells. Degranulation of bronchial mast cells from Ovx rats was reduced after in vitro challenge, an effect reverted by estradiol but not by progesterone. We suggest that the serum estradiol-to-progesterone ratio might drive cellular recruitment, modulating the pulmonary allergy and profile of release of anti-inflammatory or inflammatory cytokines. The existence of such dual hormonal effects suggests that the hormone therapy of asthmatic postmenopausal women and of those suffering of premenstrual asthma should take into account the possibility of worsening the pulmonary conditions.

14 April 2011 in Blood
Verified
Journal Article
Closed access
PDF file
Felicity N. E. GavinsFelicity N. E. Gavins
Felicity N. E. Gavins
JRJanice Russell
Janice Russell
ESElena L. Senchenkova
Elena L. Senchenkova
LPLidiana De Almeida Paula
Lidiana De Almeida Paula
Amilcar Sabino DamazoAmilcar Sabino Damazo
Amilcar Sabino Damazo
DGD. Neil Granger
D. Neil Granger
The microvasculature assumes an inflammatory and procoagulant state in a variety of different diseases, including sickle cell disease (SCD), which may contribute to the high incidence of ischemic stroke in these patients. This study provides evidence for accelerated thrombus formation in arterioles and venules in the cerebral vasculature of mice that express hemoglobin-S (βs mice). Enhanced microvascular thrombosis in βs mice was blunted by immunologic or genetic interventions that target tissue factor, endothelial protein C receptor, activated protein C, or thrombin. Platelets from βs mice also exhibited enhanced aggregation velocity after stimulation with thrombin but not ADP. Neutropenia also protected against the enhanced thrombosis response in βs mice. These results indicate that the cerebral microvasculature is rendered vulnerable to thrombus formation in βs mice via a neutrophil-dependent mechanism that is associated with an increased formation of and enhanced platelet sensitivity to thrombin.